Ads
related to: himshims.com has been visited by 10K+ users in the past month
- Low-Cost ED Treatment
Doctor-trusted generic alternatives
& FDA-approved options to treat ED.
- Regrow Hair
Stop further hair loss and grow new
hair with total treatment coverage.
- Get Hard With Rx ED Meds
Licensed providers, 100% online
process. Free & discreet delivery.
- Get Hard for Less
Treat ED for as low as $3 per use.
100% online and discreet delivery.
- Mental Health at Hims
Anxiety and depression meds to help
you feel like your best self.
- FDA-approved Viagra®
Time-tested ED treatment.
Works in as little as an hour.
- Low-Cost ED Treatment
Search results
QIAGEN's (QGEN) New Launch Expands US Syndromic Testing Menu
Zacks via Yahoo Finance· 17 hours agoZacks Rank and Key Picks QIAGEN currently carries a Zacks Rank #3 (Hold). Some better-ranked stocks...
Is Acrivon Therapeutics, Inc. (ACRV) Outperforming Other Medical Stocks This Year?
Zacks· 1 day agoThe Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is Acrivon Therapeutics, Inc. (ACRV Quick QuoteACRV - Free ...
Zimmer Biomet (ZBH) Procedure Recovery Aids Amid Macro Woes
Zacks via Yahoo Finance· 2 days agoSG&A expenses on a reported basis are expected to rise 5% in the same time frame. Key Picks Some...
Bruker (BRKR) Launches neofleX MALDI-TOF/TOF MSI System
Zacks via Yahoo Finance· 2 days agoZacks Rank and Key Picks Bruker currently carries a Zacks Rank #3 (Hold). Some better-ranked stocks...
BioLife (BLFS) Progresses in Cell & Gene Therapy With CryoCase
Zacks via Yahoo Finance· 6 days agoZacks Rank and Key Picks BioLife carries a Zacks Rank #4 (Sell) currently. Some better-ranked stocks...
QIAGEN (QGEN) Advances Precision Medicine With New QIAseq Kit
Zacks via Yahoo Finance· 3 days agoZacks Rank and Key Picks QIAGEN currently carries a Zacks Rank #3 (Hold). Some better-ranked stocks...
Omnicell (OMCL) Gains From New Offerings Amid Cost Woes
Zacks via Yahoo Finance· 3 days agoThis increased competition could result in pricing pressure and a reduced margin, which would have...
Teleflex's (TFX) Urolift Drives Market Share, Macro Woes Stay
Zacks via Yahoo Finance· 6 days agoThe commercialization of Teleflex's (TFX) UroLift in Japan has been a significant step toward making...
Reasons to Hold Charles River (CRL) in Your Portfolio Now
Zacks via Yahoo Finance· 7 days agoThe Zacks Consensus Estimate for 2024 revenues is pegged at $4.21 billion, which implies a 2%...
Here's Why You Should Hold on to Tandem Diabetes (TNDM) Now
Zacks· 1 day agoFree Report) is well-poised for growth in the coming quarters, backed by its impressive lineup of new products. The flourishing diabetes market provides a favorable opportunity for the company ...
Ads
related to: himshims.com has been visited by 10K+ users in the past month